Skip to main content

Table 1 Clinical characteristics

From: Endoscopic vacuum therapy for postoperative esophageal leak

Variables
Patients (n = 20)
Male 20 (100.0)
Age, years 66.5 (53–77)
WBC, ×103/uL 8.59 (5.59–17.48)
CRP, mg/dL 6.85 (0.58–26.74)
Organ failure 2 (10.0)
CCI score
 0 14 (70.0)
 1–3 6 (30.0)
Neoadjuvant treatment
  No 10 (50.0)
  Yes 10 (50.0)
Operation
 Ivor-Lewis operation 7 (35.0)
 3-field lymph node dissection 8 (40.0)
 McKeown operation 4 (20.0)
 Transhiatal esophagectomy 1 (5.0)
Anastomosis
 Intrathoracic anastomosis 13 (65.0)
 Cervical anastomosis 7 (35.0)
Anastomotic leak
 Time to diagnosis, days 12.5 (5–35)
 Fistula size, cm 1.75 (0.5–3.0)
 Mucosal ischemia on EGD 16 (80.0)
EVAC treatment
 Time to treatment, days 3 (0–24)
 Duration of EVAC, days 14.5 (4–56)
 Number of interventions 5 (2–12)
 Treatment failure 1 (5.0)
Hospital stay, days 49 (19–90)
Mortality 1 (5.0)
  1. WBC white blood cell, CRP C-reactive protein, CCI Charlson comorbidity index, EGD esophagoduodenoscopy, EVAC endoscopic vacuum-assisted closure
  2. Data are shown as the median with range or number (%) of patients